Clik here to view.
Vectura on the hunt for specialized lung drug business
(Reuters) — James Ward-Lilley, the former AstraZeneca executive who created a UK respiratory medicine business in June by merging Vectura and SkyePharma, is already thinking about his next deal. This...
View ArticleClik here to view.
Navidea reels in losses, boosts sales in Q3
Shares in Navidea (NYSE:NAVB) rose yesterday after the company met expectations on Wall Street with its 3rd quarter results. The Dublin, Ohio-based company pared its losses by -99.3% to -$59,377 on...
View ArticleClik here to view.
CMS acting chief Slavitt slams drug pricing
Centers for Medicare & Medicaid Services acting chief Andy Slavitt admonished pharma companies like Mylan (NSDQ:MYL) over unsustainable price increases before the Biopharma Congress in Washington...
View ArticleClik here to view.
Flamel Technologies tops Q3 revenue, EPS estimate
Shares in Flamel Technologies (NSDQ:FLML) rose today after the pharmaceutical company met expectations on Wall Street with its 3rd quarter results. The Venissieux, France-based company posted a loss of...
View ArticleClik here to view.
Catalent tops Q1 estimates, profits fall 61%
Shares in Catalent (NYSE:CTLT) rose yesterday after the drug-delivery company met expectations on Wall Street with its fiscal 1st-quarter results. The Somerset, N.J.-based company posted profits of...
View ArticleClik here to view.
Senate panel adds to call for hearings over Mylan’s EpiPen pricing
The U.S. Senate Judiciary Committee yesterday called on the Federal Trade Commission to investigate whether Mylan (NSDQ:MYL) broke the law after reports claimed the EpiPen maker prevented schools from...
View ArticleClik here to view.
Trump win boosts drug stocks
Pharmaceutical stocks surged today after Donald Trump won the U.S. presidential election, as investors concluded the threat of action on drug pricing had lessened. California’s Proposition 61, which...
View ArticleClik here to view.
Mylan misses on top & bottom lines, citing $465 million settlement
Shares in Mylan (NDSQ:MYL) rose slightly today after the pharmaceutical giant missed expectations on Wall Street with its 3rd-quarter results. The Canonsburg, Pa.-based company posted a net loss of...
View ArticleClik here to view.
California insurance board subpoenas Valeant
Valeant Pharmaceuticals (NYSE:VRX) said yesterday that it received an investigative subpoena from the California Dept. of Insurance last month over its ties to a specialty pharmacy, Philidor Rx...
View ArticleClik here to view.
Dow subsidiary presents transdermal delivery system
Dow (NYSE:DOW) subsidiary Dow Corning presented its latest drug delivery tech for transdermal therapies at the American Assn. of Pharmaceutical Sciences annual meeting. Dow Corning introduced its...
View ArticleClik here to view.
Novo Nordisk’s Fiasp wins EU nod; Danish firm plans emerging markets push
Novo Nordisk (NYSE:NVO) said today that the European Union’s Committee for Medicinal Products for Human Use issued a positive opinion on its fast-acting insulin analogue, Fiasp. The Danish company...
View ArticleClik here to view.
Are tiny ‘supermagnets’ the future of drug delivery?
Researchers from Quingdou University of Science and Technology in China developed a method to produce “supermagnets” that could one day be used as targeted drug delivery vehicles. The team’s work was...
View ArticleClik here to view.
China’s Uni-Bio Science, Luqa Pharmaceuticals ink deal for dermatology...
Uni-Bio Science (HKG:0690) said today that it inked a strategic partnership with Luqa Pharmaceuticals for the marketing of dermatology drug-device combination products. According to the agreement, the...
View ArticleClik here to view.
Light-driven motor powers nanorobot drug delivery system
Researchers proposed a nanosized, light-driven motor that is powerful enough to carry a certain load and possible act as a drug delivery system, according to the study published in the Journal of...
View ArticleClik here to view.
Injectable opioid dependence treatment succeeds in clinical trial
Camarus AB (STO:CAMX) and Braeburn Pharmaceuticals said this week that a late-stage trial of its injectable opioid dependence treatment was successful. CMAX shares surged 16% at the beginning of the...
View ArticleClik here to view.
PwC California Life Sciences report highlights continued investment, growth
The California Life Sciences Assn. and PricewaterhouseCoopers released their annual Life Sciences Industry Report, highlighting continued growth and a robust pipeline of medical devices and other...
View ArticleClik here to view.
Cumberland Pharma acquires U.S. rights to Nordic’s injectable methotrexate
Cumberland Pharmaceuticals (NSDQ:CPIX) said today that it acquired exclusive U.S. rights to Nordic Group‘s injectable methotrexate product line to treat rheumatoid arthritis, juvenile idiopathic...
View ArticleClik here to view.
DBV, BioNet-Asia study needle-free pertussis booster vaccination
DBV Technologies (NSDQ:DBVT) and BioNet-Asia said today that the independent Data & Safety Monitoring Board positively reviewed DBV’s needle-free vaccine patch technology, Viaskin, and that...
View ArticleClik here to view.
New drug capsule delivers medicine for weeks after swallowing
Researchers from Massachusetts Institute of Technology, spurred by a challenge from Bill Gates, developed a star-shaped drug capsule that can gradually release medication and stay in the stomach for to...
View ArticleClik here to view.
Report finds pressure from Congress does not budge drug prices
Committees in Congress have issued more than a dozen subpoenas to drug-makers for alleged price-hiking in the last 2 years, with members of the House and Senate collecting hundreds of thousands of...
View Article